ABBV Competitors & Alternatives
Compare AbbVie Inc with similar stocks in the same industry
Drug Manufacturers - General
ABBV
Main Stock$264.96
Tradestie Score
41
Market Cap
$431.71B
P/E Ratio
75.2
Revenue Growth
0.1%
Analyst Upside
+4.4%
Top Competitors
17 stocks in Drug Manufacturers - General| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
LLY
Eli Lilly & Co.
|
$1255.40
|
$739.95B | 42.9 | 37 | Compare |
|
JNJ
Johnson & Johnson
|
$270.24
|
$448.07B | 31.8 | 42 | Compare |
|
NVO
Novo-Nordisk A/S
|
$46.74
|
$262.92B | 11.4 | 49 | Compare |
|
AZN
AstraZeneca PLC
|
$165.98
|
$261.56B | 24.7 | 68 | Compare |
|
NVS
Novartis AG
|
$158.86
|
$254.99B | 23.6 | 50 | Compare |
|
ABT
Abbott Laboratories
|
$116.64
|
$232.30B | 37.1 | 37 | Compare |
|
MRK
Merck & Co., Inc.
|
$152.55
|
$225.13B | 122.1 | 45 | Compare |
|
AMGN
Amgen Inc
|
$439.33
|
$160.70B | 27.5 | 38 | Compare |
|
PFE
Pfizer Inc.
|
$28.07
|
$154.70B | 35.7 | 40 | Compare |
|
GILD
Gilead Sciences Inc
|
$146.12
|
$137.92B | - | 34 | Compare |
More ABBV Analysis
Data updated: Aug 24, 2026 | Industry: Drug Manufacturers - General (SIC 2834)
17 stocks in this industry